Medicine & Health News

Revolutionary CRISPR-based genome editing system treatment destroys cancer cells

Researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer. The researchers developed a novel lipid nanoparticle-based delivery system that specifically targets cancer cells and destroys them by genetic manipulation. The system, called CRISPR-LNPs,… Read More

Teeth grinding and facial pain increase due to coronavirus stress and anxiety

The stress and anxiety experienced by the general population during Israel’s first lockdown brought about a significant rise in orofacial and jaw pain, as well as jaw-clenching in the daytime and teeth-grinding at night, according to a new study from Tel Aviv University (TAU). The research also found that women suffered more from these symptoms… Read More

New genes for human deafness found in Israeli families

Until now, seven genes were known to be involved in hearing loss in Israel’s Jewish population. A new study led by Zippora Brownstein, PhD, and Prof. Karen Avraham from the Sackler Faculty of Medicine at Tel Aviv University has found that 32 genes are responsible for inherited hearing loss in Israeli Jewish families. The researchers… Read More

Google awards competitive grant to TAU for COVID-19 research, a Google fund aimed at supporting data based solutions for some of humanity’s greatest challenges, has awarded a competitive grant to Tel Aviv University for high-impact research employing Data Science and Artificial Intelligence (AI) to combat COVID-19. This step is one of many taken by Google in its ongoing effort to contribute to the… Read More

3M awards philanthropic grant to TAU for COVID-19 vaccine research

Science-based technology company 3M has awarded a significant philanthropic research grant of $400,000 to the Shmunis School of Biomedicine and Cancer Research at Tel Aviv University (TAU) to advance scientific knowledge in the global response to the COVID-19 pandemic. The grant from 3M, which has its Israel operations in Herzliya, forms part of a $5… Read More

New nanosystem from TAU enhances treatment for melanoma in animal models

Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU’s Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system that significantly enhances the effectiveness of treatment for the aggressive skin cancer melanoma. The nanocarrier is a biocompatible and biodegradable polymer, which comprises repeating… Read More